Clinical Trial Update: Japan Phase 2 Study of Niraparib in Participants With Advanced, Relapsed Ovarian Cancer [Phase 2]

View source ↗

Summary

Takeda-sponsored Phase 2 trial of Niraparib in advanced, relapsed ovarian cancer (including fallopian tube and primary peritoneal cancers) has completed with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Niraparib (Zejula) (Niraparib)

Snippet

Sponsor: Takeda | Conditions: Ovarian Cancer, Fallopian Tube Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-08-11